Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial

Flávio D Fuchs1, Sandra C Fuchs, Leila B Moreira

  • 1Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. ffuchs@hcpa.ufrgs.br

Trials
|March 8, 2011
PubMed

Insights

This study investigated if low-dose diuretics can prevent hypertension and cardiovascular events in pre-hypertensive individuals. Early use of blood pressure-lowering drugs may be a key public health strategy.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Pre-hypertension increases cardiovascular risk and often progresses to hypertension.
  • Non-drug interventions for hypertension prevention have shown limited effectiveness.
  • Blood pressure-lowering agents can reduce cardiovascular events in high-risk patients and prevent hypertension.

Purpose of the Study:

  • To evaluate the efficacy, safety, and feasibility of a population-based intervention to prevent hypertension incidence.
  • To assess the prevention of target-organ damage in individuals with pre-hypertension.
  • To investigate the role of early pharmacological intervention in cardiovascular health.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial (PREVER-prevention) involving 1250 participants aged 30-70 with pre-hypertension.
  • Intervention arms: chlorthalidone 12.5 mg plus amiloride 2.5 mg versus identical placebo.
  • Primary outcomes: hypertension incidence, adverse events, microalbuminuria, and left ventricular hypertrophy. Secondary outcomes: fatal/non-fatal cardiovascular events.

Main Results:

  • The study is ongoing; results are pending.
  • The trial is designed to detect a 40% reduction in hypertension incidence.
  • Sample size: 625 participants per group, powered for 85% with P alpha of 5%.

Conclusions:

  • Early use of diuretics may prevent hypertension and cardiovascular events in pre-hypertensive individuals.
  • This intervention, if proven effective and safe, could form the basis of a public health program in Brazil.
  • Pharmacological prevention of hypertension is a potential strategy for reducing cardiovascular disease burden.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...